Purpose
to establish methods to deliver active secretory IgA antibodies (sIgAs) to the intestine, which will be a foundation for safe and cost-effective treatments for a wide variety of intestinal pathogens, including bacteria, viruses, and toxins
Grantee
Division
Global Health
Date
NOVEMBER 2017
Region served
GLOBAL
Committed amount
$363,340
Grant topic
Support Innovative Technology Solutions
Duration (months)
19
Grantee location
Wynnewood, Pennsylvania, United States
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.